Hot
Human ALPG / ALPPL2 Protein, His Tag, low endotoxin (active enzyme, MALS verified)Cat. No. ALG-H52H9
| Molecule | Cat. No. | Product Name | Art | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| ALPG | HOT ALG-H52H9 | Human ALPG / ALPPL2 Protein, His Tag, low endotoxin (active enzyme, MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $470.00 100ug | ||
| ALPG | Avitag ALG-H52E1 | Biotinylated Human ALPG / ALPPL2 Protein, His,Avitag™ (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| ALPG | Mouse ALPG / ALPPL2 Protein, His Tag (active enzyme, MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $410.00 100ug |
| Projektname | Projektphase | Molekültyp | Molekülquelle | Krankheitsgebiet | Indikationen |
|---|---|---|---|---|---|
| ALPP/ALPPL2 mAb - 01 | PCC | Monoclonal | Humanized Mouse | Solid Tumor | Endometrial cancer,Ovarian cancer |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| ALXN-1850 | ALXN-1850 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
| Amifostine for nasoduodenal delivery (Xerient Pharma) | XER-001 | Phase 2 Clinical | Xerient Pharma | Pancreatic Neoplasms | Details |
| placenta-derived protein (Zoltan) | PALP | Clinical | Zoltan Laboratories | Cachexia; Diabetes Mellitus; Obesity | Details |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Frühestes Markenname | Frühestes Genehmigungsland | Früheste Indikation | Früheste Genehmigungsgesellschaft | Früheste Genehmigungsdatum | Indikationen | Klinische Studie |
|---|---|---|---|---|---|---|---|---|---|---|
| Amifostine | WR-2721C; NSC-296961; YM-08310; S-8744; SAPEP; WR-2721 | Approved | Medimmune Llc | Ethyol, 天地达, 安福定 | Mainland China | Cytoprotective adjuvant | China Grand Automotive Services Group Co Ltd | 1995-12-08 | Acute Radiation Syndrome; Bone Marrow Diseases; Breast Neoplasms; Carcinoma; Cytoprotective adjuvant; Fanconi Anemia; Gestational Trophoblastic Disease; Head and Neck Neoplasms; Hodgkin Disease; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mucositis; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Nasopharyngeal Neoplasms; Neurotoxicity Syndromes; Neutropenia; Ovarian Neoplasms; Peripheral Nervous System Diseases; Prostatic Neoplasms; Salivary Gland Diseases; Sarcoma; Solid tumours; Trigeminal Neuralgia | Details |